Overview

Welcome to Dwaey, specifically on ASTHAVENT Respules 1mg/ml Nebulization/Solution for page.
This medicine contains an important and useful components, as it consists of Salbutamol (as sulfate).
ASTHAVENT Respules 1mg/ml is available in the market in concentration 2.5mg/2.5ml and in the form of Nebulization/Solution for.

CIPLA LTD. is the producer of ASTHAVENT Respules 1mg/ml and it is imported from INDIA, The most popular alternatives of ASTHAVENT Respules 1mg/ml are listed downward .

Mode Of Action & Indication

Salbutamol is a direct-acting sympathomimetic with beta-adrenergic activity and selective action on ?2 receptors, producing bronchodilating effects. It also decreases uterine contractility.

Indication

• Acute severe asthma
• Severe bronchospasm

Precaution

Hyperthyroidism, myocardial insufficiency, arrhythmias, susceptibility to QT-interval prolongation, HTN, DM, glaucoma, hypokalaemia, seizure disorder. Renal impairment. Elderly. Pregnancy and lactation. Monitoring Parameters Monitor BP, heart rate, electrolyte and fluid balance; glucose, lactate and K levels. Lactation: Unknown whether drug is excreted in milk; not recommended

Side Effects

• >10% Tremor (20%)
• Nervousness in children aged 2-6 years (20%)
• Insomnia in children aged 6-12 years receiving 4-12 mg q12hr (11%) 1-10% Nausea (10%)
• Fever (1.6-9%)
• Bronchospasm (8%)
• Vomiting (7%)
• Headache (4-7%)
• Dizziness (1-7%)
• Cough (5%)
• Allergic reactions (4%)
• Otitis media (3.3%)
• Epistaxis in children (3%)
• Increased appetite (3%)
• Urinary tract infection (3%)
• Dry mouth (<3%)
• Eructation or flatulence (<3%)
• Increased sweating (<3%)
• Pain (2.7%)
• Dyspepsia (1-2%)
• Hyperactivity (1-2%)
• Chills (<2%)
• Lymphadenopathy (<2%)
• Ocular pruritus (<2%)
• Sweating (<2%)
• Conjunctivitis in children aged 2-6 years (1%)
• Dysphonia (>1%)
• Flu syndrome
• Nervousness <1% Epigastric pain
• Epistaxis in adults
• Hyperactivity in children Frequency Not Defined Adverse reactions such as hypertension
• angina
• vertigo
• central nervous system stimulation
• insomnia
• headache
• metabolic acidosis
• and drying or irritation of oropharynx Hypersensitivity
• Hypokalemia
• Increased blood glucose levels
• Prolonged QT interval and ST-segment depression
• Sleeplessness
• Tachycardia (incidence varies with formulation) Urticaria
• angioedema
• rash
• bronchospasm
• and oropharyngeal edema (rare) Potentially Fatal: Potentially serious hypokalaemia after large doses.

Contra indication

Salbuatmol inhaler is contraindicated in patients with a history of hypersensitivity to any of its components. Although intravenous Salbutamol, and occasionally Salbutamol tablets, is used in the management of premature labour uncomplicated by conditions such as placenta praevia, ante-partum haemorrhage or toxaemia of pregnancy, Salbutamol inhaler preparations are not appropriate for managing premature labour. Salbutamol preparation should not be used for threatened abortion during the first or second trimesters of pregnancy.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks